Risk factors for acute renal failure requiring dialysis after liver transplantation. 1998

I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
Department of Surgery, Hospital General Vall D'Hebron, Barcelona, Spain.

Acute renal failure (ARF) is a common and severe complication after liver transplantation (LT). The aim of this study was to ascertain the impact of ARF requiring dialysis in the outcome of LT and to analyze the risk factors leading to this event in the early post-operative period. From October 1988 to December 1994, 172 LT were performed in 158 patients. Postoperative ARF occurred in 88 transplants (51.1%) during the early postoperative period: mild ARF was found in 46 (serum creatinine 1.5-3 mg/dl), moderate ARF in 12 (serum creatinine > 3 mg/dl) and severe ARF in 30 (serum creatinine > 3 mg/dl with dialysis requirement). Preoperative, intraoperative, and postoperative variables were studied, comparing patients presenting severe ARF with the remaining patients. Postoperative mortality in the dialysed group was much higher than in the non-dialysis group (50% vs. 13.4%)(p < 0.001) and 1-yr actuarial graft survival was 73.4% for the non-dialysed group compared with 40.9% for the dialysed group (p < 0.05). Among 38 variables investigated, only two factors had independent prognostic value in multivariate analysis: preoperative serum creatinine > 1.5 mg/dl (OR = 4.4, p = 0.006) and graft dysfunction grades III-IV (OR = 8.9, p = 0.001). In conclusion, ARF is a severe complication post-LT; its appearance could be predicted in patients with pre-transplant renal dysfunction, severe graft dysfunction, or both. However, in many cases renal function may revert to normal if treated aggressively with early dialysis support.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
March 2006, Kidney international,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
July 2003, Renal failure,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
November 2007, Acta anaesthesiologica Scandinavica,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
May 2006, Transplantation proceedings,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
September 1992, Ugeskrift for laeger,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
January 1991, Scandinavian journal of thoracic and cardiovascular surgery,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
February 2006, Revista espanola de anestesiologia y reanimacion,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
April 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
July 2020, Journal of clinical medicine,
I Bilbao, and R Charco, and J Balsells, and J L Lazaro, and E Hidalgo, and L Llopart, and E Murio, and C Margarit
October 2014, Transplantation proceedings,
Copied contents to your clipboard!